BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim ... truly look forward to our collaboration with the WHO Foundation and its partners as we want to increase access to life-saving ...
By driving life forward and leading the science that results in breakthrough therapies, Boehringer Ingelheim stays true to its purpose of improving the health of communities today, and for future ...
Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.
In a concerted effort to address critical unmet healthcare needs within Indigenous communities, Boehringer Ingelheim (Canada) Ltd., Bimaadzwin and Indigenous health policy leaders across Canada, share ...
Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...
Tokyo, Japan and Cambridge, UK, 23 October 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – is pleased to announce that it has won ...